Biotechnology
Biotechnology, for which R&D costs are high in spite of the aim to decrease health expenses, and the innovative pharmaceutical and medical device market, are used for rare diseases and are expected to continue growing globally in the long term. Statements from both the government and private sectors clearly demonstrate Turkey's aim to be an important player in the globally expanding biotechnology and biosimilar industry. So, at PwC, we provide advisory, audit and tax services regarding state incentives and their scope, localisation regulations and action plans, evaluating profitability, effectiveness and competence of investments in Turkey, and the best global practices in the public and private sectors by health industry stakeholders, including evaluating their applications in Turkey.